Evidence map›Paper›PMID 39609097›Full record

ArticleAndrology2025

A WHO 2021-based comprehensive scheme outlining sperm parameters' associations with IVF outcomes in PGT-A cycles.

Rossella Mazzilli, Danilo Cimadomo, Federica Innocenti, Marilena Taggi, Greta Chiara Cermisoni, Sara Ginesi, Lisa Dovere, Laura Albricci, Maurizio Guido, Maria Rosaria Campitiello and 7 more

Abstract read
In one paragraph

Article in Andrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Rossella MazzilliDepartment of Clinical and Molecular Medicine, University "Sapienza" of Rome, Rome, Italy.
Danilo CimadomoIVIRMA Global Research Alliance, Genera, Clinica Valle Giulia, Rome, Italy.
Federica InnocentiIVIRMA Global Research Alliance, Genera, Clinica Valle Giulia, Rome, Italy.
Marilena TaggiIVIRMA Global Research Alliance, Genera, Clinica Valle Giulia, Rome, Italy.
Greta Chiara CermisoniIVIRMA Global Research Alliance, Genera, Clinica Valle Giulia, Rome, Italy.
Sara GinesiDepartment of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, Pavia, Italy.
Lisa DovereIVIRMA Global Research Alliance, Genera, Clinica Valle Giulia, Rome, Italy.
Laura AlbricciIVIRMA Global Research Alliance, Genera, Clinica Valle Giulia, Rome, Italy.
Maurizio GuidoDepartment of Clinical Medicine, Public Health, Life Sciences and the Environment, University of L'Aquila, L'Aquila, Italy.
Maria Rosaria CampitielloDepartment of Obstetrics and Gynecology and Physiopathology of Human Reproduction, ASL Salerno, Salerno, Italy.
Susanna FerreroIVIRMA Global Research Alliance, Genera, Clinica Valle Giulia, Rome, Italy.
Antonio CapalboJuno Genetics, Rome, Italy.ORCID 0000-0003-0109-323X
Alberto VaiarelliIVIRMA Global Research Alliance, Genera, Clinica Valle Giulia, Rome, Italy.
Filippo Maria UbaldiIVIRMA Global Research Alliance, Genera, Clinica Valle Giulia, Rome, Italy.
Alberto FerlinDepartment of Medicine, Unit of andrology and reproductive medicine, University of Padova, Padova, Italy.ORCID 0000-0001-5817-8141
Laura RienziIVIRMA Global Research Alliance, Genera, Clinica Valle Giulia, Rome, Italy.
Gianluca GennarelliIVIRMA Global Research Alliance, Livet, Turin, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo examine the association between semen parameters, assessed according to World Health Organization (WHO)-2021 criteria, and paternal body mass index (BMI) and age, with embryological and clinical outcomes in ICSI cycles involving preimplantation genetic testing for aneuploidy (PGT-A).

designRetrospective study at a private in vitro fertilization (IVF) clinic. SUBJECTS: 3101 couples undergoing 4013 intracytoplasmic sperm injection (ICSI) + PGT-A cycles with own-oocytes (years 2013-2021).

interventionWe performed trophectoderm biopsy, and comprehensive chromosome testing to report uniform aneuploidies and vitrified-warmed euploid single-blastocyst-transfers. Regression analyses adjusted for relevant confounders were conducted to outline putative associations of semen analysis and characteristics and paternal BMI and age with all embryological/clinical outcomes.

resultsMaternal age was the only significant confounding variable affecting euploidy blastocyst rate (EBR) (primary embryological outcome). When categorized, motility < 5

conclusionsThis comprehensive analysis provides IVF professionals with useful figures to counsel infertile couples about their chances of success, taking into account the impact of semen characteristics and paternal BMI and age. These estimates are valuable for personalized decision-making about the most effective reproductive strategies to adopt, especially not underestimating male factor, by improving sperm concentration and motility whenever possible before assisted reproductive technologies.

Indexed as

AneuploidyFertilization in VitroPreimplantation DiagnosisSemen AnalysisSpermatozoaAdultBody Mass IndexFemaleGenetic TestingHumansMaleMaternal AgePregnancyPregnancy RateRetrospective StudiesSperm Injections, Intracytoplasmiccumulative live birth rateICSIpaternal agePGT‐Asperm factor

Identifiers

PMID39609097
PMCPMC12476224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.